Top 50 Biotechnology Startup Investors in Ireland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Enterprise Ireland
VC Fund
|
29 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $494k–$12M |
|
SOSV
VC Fund
|
19 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Western Development Commission
VC Fund
|
13 | Ireland, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $642k–$11M |
|
Irrus Investments
VC Fund
|
8 | Ireland, Sweden, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $713k–$8.8M |
|
Kernel Capital
VC Fund
|
7 | Ireland, United Kingdom, France | Seed, Series A | Software, Information Technology, Health Care | $531k–$9M |
|
Seroba Life Sciences
VC Fund
|
6 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $4.6M–$105M |
|
Fountain Healthcare Partners
VC Fund
|
6 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
AIB Seed Capital Fund
VC Fund
|
5 | Ireland, United States, Jersey | Seed, Series A | Software, Health Care, Medical | $549k–$8.1M |
|
Atlantic Bridge
VC Fund
|
5 | United States, Ireland, United Kingdom | Series A, Series B | Software, Information Technology, Artificial Intelligence | $4.5M–$62M |
|
HBAN Medtech Syndicate
VC Fund
|
4 | Ireland | Seed, Series B | Medical Device, Medical, Health Care | $1.3M–$2.1M |
|
HBAN
VC Fund
|
4 | Ireland, United Kingdom, United States | Seed, Series A | Health Care, Software, Medical Device | $625k–$8.8M |
|
European Investment Bank
VC Fund
|
4 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$658M |
|
Boole Investment Syndicate
VC Fund
|
3 | Ireland, Estonia, United States | Seed, Series A | SaaS, Software, Biotechnology | $642k–$1.6M |
|
The Yield Lab Europe
VC Fund
|
3 | Ireland, France, United Kingdom | Seed, Series A | AgTech, Agriculture, Biotechnology | $531k–$10M |
|
Furthr VC
VC Fund
|
3 | Ireland | Seed, Pre-Seed | Medical Device, Medical, Software | $878k–$3.9M |
|
Atlantic Bridge University Fund
VC Fund
|
3 | Ireland, United States | Seed, Series A, Series B | Medical Device, Health Care, Big Data | $823k–$80M |
|
Act Venture Capital
VC Fund
|
3 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $823k–$13M |
|
Ascentifi
VC Fund
|
2 | Ireland | Seed, Series A | Health Care, Medical Device, Medical | |
|
Elkstone Capital Partners
VC Fund
|
2 | Ireland, United Kingdom, United States | Seed, Series A | Software, Artificial Intelligence, Health Care | $610k–$20M |
|
SVG Ventures
VC Fund
|
2 | United States, Canada, Ireland | Pre-Seed, Seed | AgTech, Agriculture, Farming | |
|
Infinity Capital
VC Fund
|
2 | United States, Ireland, Canada | Series B, Series D | Semiconductor, E-Commerce, Electronics | |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$88M |
|
Enterprise Equity
VC Fund
|
2 | Ireland, United States, United Kingdom | Seed, Series B | Software, Information Technology, Health Care | $549k–$7.5M |
|
ARCH Venture Partners
VC Fund
|
2 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7.8M–$250M |
|
Lightstone Ventures
VC Fund
|
2 | United States, Ireland, Singapore | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7M–$105M |
|
Sanara MedTech
VC Fund
|
1 | Ireland | Corporate Round | Medical, Biotechnology, Medical Device | |
|
Others Others
Angel
|
1 | Spain, Germany, Ireland | Seed, Pre-Seed | Biotechnology, Software, B2B | |
|
Johnson & Johnson Innovation
VC Fund
|
1 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | |
|
Sol Global investments
VC Fund
|
1 | United States, Canada, Ireland | Corporate Round, Series A, Series B | Health Care, Cannabis, Cloud Computing | |
|
MML Capital Partners
VC Fund
|
1 | United Kingdom, France, United States | Private Equity, Series A | Manufacturing, Packaging Services, Information Technology | |
|
Inventages Venture Capital Investment Inc.
VC Fund
|
1 | United States, United Kingdom, Canada | Series A, Series B | Biotechnology, Health Care, Therapeutics | |
|
Carbery Group
VC Fund
|
1 | Ireland | Seed | Life Science, Biotechnology, Marine Technology | |
|
John Purdy
Angel
|
1 | Ireland | Seed | Software, FinTech, Medical | |
|
KBI Biopharma
VC Fund
|
1 | United States, Ireland | Seed, Series A, Series D | Biotechnology, Life Science, Medical | |
|
Development Capital
VC Fund
|
1 | Ireland, United States, United Kingdom | Seed, Private Equity | Manufacturing, Telecommunications, VoIP | |
|
Medicxi
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series A, Series B, Seed | Biotechnology, Health Care, Pharmaceutical | |
|
Polaris Partners
VC Fund
|
1 | United States, Ireland, Singapore | Series B, Series A, Series C | Health Care, Biotechnology, Medical | |
|
The Yield Lab
VC Fund
|
1 | United States, Argentina, Brazil | Seed, Series A, Convertible Note | Agriculture, Biotechnology, AgTech | |
|
Claret Capital Partners
VC Fund
|
1 | United Kingdom, Germany, United States | Debt Financing, Series A | Software, Information Technology, Mobile | |
|
GV
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Software, Health Care, Biotechnology | |
|
Clay Capital
VC Fund
|
1 | France, Israel, Germany | Series A, Series B | Food and Beverage, Biotechnology, Health Care | |
|
WxNW
VC Fund
|
1 | Ireland | Seed | Sales, Consumer, Marketing | |
|
Moffett Investment Holdings
VC Fund
|
1 | Ireland | Series A, Series B | Medical, Health Care, Biotechnology | |
|
Woodford Investment Management
VC Fund
|
1 | United Kingdom, United States, Ireland | Series B, Series A | Biotechnology, Health Care, Medical | |
|
Conor Sheahan
Angel
|
1 | Ireland | Seed | Medical, Biopharma, Health Care | |
|
Declan Magee
Angel
|
1 | Ireland | Seed | B2B, CRM, SaaS | |
|
Fulcrum Global Capital
VC Fund
|
1 | United States, Canada, India | Series A, Series B | Biotechnology, Agriculture, Farming | $3.8M–$20M |
|
Cultivian Sandbox Ventures
VC Fund
|
1 | United States, Canada, Germany | Series A, Series B, Series C | Agriculture, Biotechnology, Farming | $2M–$80M |
|
Medtech Syndicate Nominee
VC Fund
|
1 | Ireland | Seed, Series A | Medical, Health Care, Medical Device | |
|
Tekla Capital Management
VC Fund
|
1 | United States, Switzerland, France | Series B, Series C, Series A | Biotechnology, Health Care, Therapeutics | $10M–$215M |
| Access all 206 investors in Ireland Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 506
- Round size: Seed $494k–$3.3M; Series A $2.2M–$12M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- Tirlan — Tirlan is an agricultural company that supplies agri-food and farm input materials to the framing sector.
- Pulsate — Pulsate enables direct communication with customers based on their location, context, interests and behaviours. Pulsate allows you to design and push rich media content directly to customers devices. Deepen the relationship by establishing a customer dialogue. Allow users to reply to your campaigns, provide feedback and keep complaints outside ofsocial media. Maximize foot traffic by targeting street level or competitor locations. Combine with segmentation for optimal results. iBeacons:tm: enable you to understand indoor customer location and context with incredible accuracy. Easily manage deployment and configuration of iBeacons:tm: with the Pulsate cloud platform. Gain a deeper understanding of your mobile customers and a comprehensive view of each mobile campaign.
- Lakeland Dairies — Lakeland Dairies, a major dairy processing co-operative, operates within a fifteen county catchment area across the northern half of the island of Ireland. The Group processes about one billion litres of quality milk annually into a range of value added dairy foodservice products and functional dairy food ingredients.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 43
- Round size: Seed $642k–$3.7M; Series A $2.2M–$11M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
- Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 34
- Round size: Seed $713k–$3.8M; Series A $2.2M–$8.8M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Bounce Insights — Bounce Insights is a digital consumer research platform. It provides a direct link between brands and any consumer they needed to speak to by maintaining a community of active, engaged respondents on their mobile app.
- Adama Innovations — Adama Innovations have a disruptive technology for advanced manufacturing. The company have developed a simple process for creating patterns, on a scale invisible to the human eye, on ultra-hard materials.The micro patterns can be applied to injection molds and forming dies used for the fabrication of medical devices, improving theircapability and reducing the cost of manufacture. Other applications include labelling and anti-counterfeiting technology.The company's first product is a nano-scale probe fabricated in diamond, for metrology applications in high-tech manufacturing.The company is a spin-out from CRANN, the flagship nanotechnology institute in Trinity College Dublin.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 91
- Round size: Seed $531k–$4.4M; Series A $1.4M–$9M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $34M in 2013
Portfolio highlights
- Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
- Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 48
- Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $111M in 2017
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Novate Medical — NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device thatsimultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.
- INNOVO by Atlantic Therapeutics — INNOVO is a completely non-invasive, clinically proven and long-lasting solution to urinary incontinence and bladder weakness. See results in 4 weeks!
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 49
- Round size: Series A $6.6M–$44M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $128M in 2019
Portfolio highlights
- Opsona — Drug development firm focused on immunology. They are headquartered in Dublin, Ireland. Opsona Therapeutics is one of Europe's most innovative and dynamic drug development companies. We are at the forefront of drug development in immunology research, with particular focus on the innate immunity pathways. Since its founding in 2004,Opsona has validated and developed a series of exciting new drug candidates and strategies which modulate the human innate immune system. We are located in Dublin, Ireland.
- Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States, Jersey
Investor stats
- Total investments: 49
- Round size: Seed $549k–$3.3M; Series A $1.1M–$8.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 138
- Round size: Series A $4.5M–$26M; Series B $10M–$62M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $88M in 2021
Portfolio highlights
- GloNav — GloNav develops global positioning system and satellite navigation technologies and products for the wireless handset and mobile consumer electronics device markets. It offers global positioning system radio frequency integrated circuits and single chip assisted-global positioning systems, which are used for low dropout tracking and cellularhandset integration. The company was founded in 2006 and is based in Newport Beach, California. It has locations in the United States, the United Kingdom, Ireland, and Taiwan. As of January 2008, GloNav, Inc. operates as a subsidiary of NXP B.V.
- Elisity — Elisity Cognitive Trust delivers identity-based segmentation and least privilege access without the need to reconfigure networks and micromanage hardware.
- Luminate Medical — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
HBAN Medtech Syndicate
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series B
- Geography: Ireland
Investor stats
- Total investments: 12
- Round size: Seed $1.3M–$2.1M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 65
- Round size: Seed $625k–$3.5M; Series A $1.2M–$8.8M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- Glitch Ads — Launch AI Powered Google Ad Campaigns in Minutes. Think of us like an agency in a box. Built for speed. Priced for scaling companies. Powered by AI.
- SeeMeHired — SeeMeHired is a cloud-based platform to automate much of the recruitment process, including engaging, selecting, and hiring job candidates.
- Mountain Technologies — Mountain Technologies is an innovative Northern Ireland-based startup that transforms mountain resort operational management.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 360
- Round size: Post-IPO Debt $18M–$658M; Debt Financing $16M–$384M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Affibody — Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a largenumber of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
- RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
- Metso Outotec —
Boole Investment Syndicate invests in new technology start-up's with scalability.
Show more...Investment focus
- Industry: SaaS, Software, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, Estonia, United States
Investor stats
- Total investments: 9
- Round size: Seed $642k–$1.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
The Yield Lab Europe is a €55m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.
Show more...Investment focus
- Industry: AgTech, Agriculture, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, France, United Kingdom
Investor stats
- Total investments: 36
- Round size: Seed $531k–$3M; Series A $2.1M–$10M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $52M in 2021
Portfolio highlights
- BBLeap — BBLeap is a company that operates in the manufacturing industry, specifically focusing on the agricultural sector. The company's main offering is the LeapBox system, a modular solution that can be attached to any new or used sprayer. This system is designed to enhance the efficiency and effectiveness of crop spraying, addressing the issue ofover-application and weak spots in fields. BBLeap's approach, termed 'Farming On Plant Level', aims to consider individual plant needs and environmental factors such as soil conditions and weather. The company's vision is to provide better spraying equipment to the agricultural sector, contributing to more sustainable and precise farming practices.
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.
Show more...Investment focus
- Industry: Medical Device, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Ireland
Investor stats
- Total investments: 26
- Round size: Seed $878k–$3.9M; Pre-Seed $878k–$2.2M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $35M in 2019
Portfolio highlights
- Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
- LaNua Medical — At LaNua Medical it is our mission to develop disruptive image-guided technologies providing safe and effective endovascular solutions.
- STRATxAI — STRATxAI is a WealthTech Company based in Dublin, Ireland. Specialising in AI-driven model portfolios, combining decades of expertise with proprietary AI to serve Advisors and Institutional Investors. STRATxAI Model Portfolios are built to navigate market complexity and deliver attractive risk-adjusted returns. Through close collaboration withclients, we create bespoke portfolios tailored to their unique needs, preferences and risk profiles. Alana, our proprietary engine leverages advanced machine learning algorithms to streamline the implementation and management of adaptive. multi factor strategies.
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more...Investment focus
- Industry: Medical Device, Health Care, Big Data
- Stage:Seed, Series A, Series B
- Geography: Ireland, United States
Investor stats
- Total investments: 31
- Round size: Seed $823k–$3.8M; Series A $3.1M–$12M; Series B $16M–$80M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- AYLIEN — Aylien is an artificial intelligence startup that focuses on creating technologies that help machines understand human languages better. The firm provides Text Analysis and News API's that allow users to make sense of human-generated content at scale. AYLIEN also provides a range of content analysis solutions to developers, data scientists,marketers and academics. Their core offerings include packages of information retrieval, machine learning, natural language processing and image recognition APIs.
- Siren — Siren is a software company that provides an Investigative Intelligence platform to complex organizations and derive business value. The platform provides a unique combination of search, business intelligence, big data, link analysis and knowledge representation which advances the way organizations address some of the world’s most importantdata-driven problems.Siren makes it easier to use the data you collect to answer questions and make links, find patterns and relationships. It also uniquely enables this in real-time at a scale that companies and government organizations require. it easy to leverages and deploy data directly on backends such as Elasticsearch, relational databases, virtual data warehouses, and graph databases.Siren was awarded the Technology Innovation of the Year and Enterprise of the Year (SME) at the Information Technology Association of Galway (ITAG) Excellence Awards and also was named the Irish Startup of the Year at Ireland’s National Tech Excellence Awards.Siren was founded in 2014 and is based in Galyway, Ireland.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 154
- Round size: Seed $823k–$5M; Series A $2.3M–$13M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $164M in 2022
Portfolio highlights
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- Engage-EHS — EcoOnline's easy-to-use software system is helping companies to transform their approach to health & safety, chemical safety & learning data reporting.
- SilverCloud Health — SilverCloud Health is the trusted on-demand virtual mental health platform - Delivering proven clinical outcomes at scale. Virtual therapy and care
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 8
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
- X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 87
- Round size: Seed $610k–$5M; Series A $5.5M–$20M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $110M in 2023
Portfolio highlights
- Danalto — Simple, cost-effective, high-accuracy Location Services for large open environments, both indoor and outdoor. Asset Tracking made simple!
- MEG — MEG is a powerful end-to-end Quality Management System for healthcare. Manage quality, patient safety, compliance and accreditation processes all from one place.
- Retrograde — Retrograde is a Software Development company.
We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.
Show more...Investment focus
- Industry: AgTech, Agriculture, Farming
- Stage:Pre-Seed, Seed
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 86
- Lead/follow: no public data
Portfolio highlights
- FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
- Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
- Iamus Technologies — Iamus Technologies Limited is an Artificial Intelligence & Robotics company based in Ireland that has developed poultry specific robotic technology that empowers poultry farmers to make better and safer production decisions. Over the last 2 years we have been working globally with poultry processors in identifying KPIs that our robots cancontinuously gather on the ground in poultry sheds and feedback instantly to both producer and the relevant personnel back at the processing plant. Results to date are impressive with automatic and accurate data recovery from the birds on every part of the floor and analysis with real-time intervention now possible. These factors are key in addressing the growing demands of modern, intensive broiler production with the Iamus robot & platform meeting these requirements.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.
Show more...Investment focus
- Industry: Semiconductor, E-Commerce, Electronics
- Stage:Series B, Series D
- Geography: United States, Ireland, Canada
Investor stats
- Total investments: 33
- Lead/follow: no public data
Portfolio highlights
- AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
- BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
- Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 126
- Round size: Series A $5.7M–$55M; Series B $12M–$88M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $549k–$2.2M; Series B $2.6M–$7.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 387
- Round size: Series A $7.8M–$212M; Series B $13M–$250M; Series C $15M–$175M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Ultivue — Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that helps to understand of biology and medicine. Ultivue's products are designed for fluorescent microscopy-based research and willeventually be valuable for clinical diagnostic use. It was founded in 2015 and headquartered in Cambridge, Massachusetts.
- EGenesis — At eGenesis, we envision a world where transplantation is accessible to all. We develop safe and effective human-compatible organs for transplantation.
- Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 84
- Round size: Series A $7M–$105M; Series B $18M–$100M; Series C $20M–$105M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- Earlens — Earlens is the world's first and only hearing aid solution to directly vibrate the eardrum, delivering a more complete sound than any other hearing aid.
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- Claret Medical — Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged duringvascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California.
Sanara MedTech is in the business of improving patient outcomes through advanced healing solutions and biotechnology. Call us at 817-529-2300!
Show more...Investment focus
- Industry: Medical, Biotechnology, Medical Device
- Stage:Corporate Round
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Biomimetic Innovations — Biomimetic Innovations is a medical device company that specializes in the development and commercialisation of synthetic biomaterial technology for tissue repair.
Others Others
Show more...Investment focus
- Industry: Biotechnology, Software, B2B
- Stage:Seed, Pre-Seed
- Geography: Spain, Germany, Ireland
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Conektto — Design, Build & Test API in minutes. Conektto is the industry's first API SDLC platform that intelligently generates artifacts.
- Gheorg — Around 1 million children in Australia have diagnosable anxiety. Two-thirds of them will never get the help they need. Gheorg is on a mission to change that. We're aiming to reduce childhood anxiety and our new app helps parents and children at home. Sign up to get the app on our website.
- Hooke Bio — Hooke Bio is a new Pharmaceutical company operating in the preclinical to early stages of drug discovery. It draws its strength from the close co-operation it has between its biologists and engineers. The engineers design, patent and test new microfluidic technology: the scientists apply the technology to finding new therapeutics.
JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 113
- Lead/follow: no public data
Portfolio highlights
- G.I. Windows — G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology. This technology will allow less invasive surgery and offer the capability of developing more procedures new to the world. The company is creating a new category in healthcare designed to create less invasive surgery and reducehealthcare costs.G.I. Windows is committed to innovation that helps improve the way diagnostic and interventional procedures impact the essential balance between both patients and the healthcare system. It was founded in 2012 and is headquartered in West Bridgewater, Massachusetts, United States.
- HistoSonics — HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
- Aro Biotherapeutics — Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
Tuned for performance. SOL Global Investments is a diversified private equity firm targeting best-in-class companies that operate in ultra-high growth industries. Our team has a proven track record of identifying pioneering businesses that are poised to disrupt the status quo and take
Show more...Investment focus
- Industry: Health Care, Cannabis, Cloud Computing
- Stage:Corporate Round, Series A, Series B
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Semasio — The Fyllo Compliance Cloud is a suite of software and services that enable organizations to navigate today’s ever-changing regulatory landscape, streamline compliance, and scale with speed. Mainstream brands also use the Fyllo Data Marketplace to target previously inaccessible cannabis and CBD consumers.The company was founded in 2019 and isheadquartered in Chicago, Illinois.
- Cityrow Go — Cityrow Go is a rowing-based fitness app for smartphones or tablets. It offers rowing classes programmed to deliver an effective, efficient, and motivating workout to the at-home user. It was founded in 2013 and is based in New York, United States.
- MCQ Markets — Start Investing in Investment-Grade Collector Cars with just $100. MCQ gives you access to invest in the same high-performance assets collectors and institutions are competing for.
MML Capital Partners is an independent investment firm, with over twenty years of history, focused on providing capital to businesses for expansion/acquisitions, management-led equity deals, recapitalisations and buy-outs.
Show more...Investment focus
- Industry: Manufacturing, Packaging Services, Information Technology
- Stage:Private Equity, Series A
- Geography: United Kingdom, France, United States
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- RAVL — Step into the future with RAVL and our revolutionary financial service technology solutions. We're not just building tech; we're crafting the future of financial services. Unleashing potential, one innovative solution at a time. Let's strategize, deliver, and repeat excellence together.
- SCPACK GROUP — SCPACK GROUP is a packaging and containers manufacturing company for wine, cosmetics and more.
- Ross-shire Engineering — Trusted water technology solutions and products for purifying drinking water, recycling effluent and cleaning water in industrial processes.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals,enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 37
- Lead/follow: no public data
Portfolio highlights
- Accera — Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.
- XOLUTION — XOLUTION is the most advanced reclosable beverage container solution. Already in its prototype state, the new XO resealable can won the Can of the Year Award in Dubai in 2009 (Winner Silver - Category Prototype) and was enhanced and refined since, involving extensive market research and field testing. With the can now entering the consumer beveragemarket, they are confident that the product resembles a step forward for XOLUTION in becoming the market leader in this field. XOLUTION GmbH is headquartered in Munich, Germany. In 2008, Marc von Rettberg was named Chief Executive of the company. He joined Christian Bratsch, Vice President R&D, to introduce innovative designs to the beverage packaging industry for reclosable beverage cans.Rettberg and Bratsch established new product design guidelines with a clear focus on values and benefits for the entire supply chain. The innovative beverage can ends were required to offer easy usage to the consumer (intuitive, easy to open and reseal), easy integration for the beverage filler in the existing processes (no major adjustments to the filling line), easy handling for the can maker (XO reclosable can ends based on standard shells), and improved commercialization for the beverage brand (unique branding options). And, of course, the focus was set on providing these benefits at a reasonable overall cost.In 2009, Can Maker Magazine recognized the XOLUTION innovative resealable can with the Silver Award in the Prototype category for the XO-400 reclosable beverage can lid. Since Time-to-Market is a key challenge for all innovators, Rettberg and Bratsch have created a competitive advantage of rapid prototyping and testing capabilities in their Salzburg R&D Center. XOLUTION GmbH is managed by one of the most competent teams in the business. With long-term experiences in their respective fields, their leading specialists guarantee the best coverage of all business areas from prototyping, R&D and product management to trading and distribution. With their knowledge, the XO Resealable Can was successfully converted from a simple vision to a technologically sophisticated product that will have a significant influence on the canned beverage market.
- Ripple Foods — Ripple Foods offers a nutritious & delicious milk alternative that is 100% dairy-free, vegan, nut-, lactose- & gluten-free. Discover more about Ripple milk!
Pioneering research and expertise in action. Through innovati drive new product innovation that creates value for our.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Marine Technology
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Pure Ocean Algae — Pure Ocean Algae is a biotechnology company that integrates value chains from macro-algae and other marine resources. The company has over the winter of 2019/20 deployed its first trial lines of Palmaria palmata to sea, with initial results being extremely positive. It has also taken primary research in tank-based vegetative production andsucceeded in developing a pilot commercial plant that can produce commercial volumes of Palmaria palmata, at levels approaching 100% per week.
John Purdy
Show more...Investment focus
- Industry: Software, FinTech, Medical
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- dimply — The experience & engagement platform for financial enterprises.
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
- FlowForma — Unlock competitive advantage with FlowForma, the #1 no code digital process automation software & business process management tool. Get a free trial now!
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, and more.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Medical
- Stage:Seed, Series A, Series D
- Geography: United States, Ireland
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
- GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
- Comera Life Sciences — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.
At Development Capital, they are aware of the significant growth opportunities available to mid-sized companies and understand the management teams’ unique requirement for not only finance, but also for a funding partner who will bring experience, expertise and international reach to assist secure and maximise the business growth opportunity.Development Capital provides investee companies with a unique and unprecedented partnership approach which will maximise the growth opportunity in the most prompt and efficient manner. In addition to their experienced Investment Directors, their partners include:High profile and experienced Industry Experts who will provide direction and support to investee companies; andMajor Irish Corporates who have committed not only funding but also their international experience.
Show more...Investment focus
- Industry: Manufacturing, Telecommunications, VoIP
- Stage:Seed, Private Equity
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- IP Telecom — Ireland's most competitive SME & Enterprise VoIP provider. We are Ireland's leading VoIP Phone Systems Provider. Connect your business to the technology of today.
- Nomadic Dairy — Nomadic Dairy is a growing, premium branded yogurt manufacturer. The company supplies multiple products across the UK and Republic of Ireland.
- Spotlight Oral Care — Spotlight Oral Care aims to create the best oral health products, to educate and promote oral care, empowering people to engage with true customised preventative oral care.
Medicxi is an investment firm that focuses on the life sciences sector. It was established in 2016 by the former Index Ventures life sciences team, who have been active for over 20 years and have significant experience in drug discovery and the development of therapeutics for unmet medical needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- Curevo — focused on a new generation of adjuvanted subunit vaccines Learn More Our Focus We're dedicated to developing non-mRNA vaccines for unmet medical needs Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation non-mRNA vaccines. We focus on one need at a time, allowing us to bring effective and better-tolerated vaccines to market quickly
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- Palladio Biosciences — Palladio Bio is a clinical-stage company developing transformative medicines for orphan diseases of the kidney. The company specializes in the fields of biotechnology, pharmaceutical. and therapeutics. Its products are designed for renal disease, kidney disease, and polycystic kidney disease.The company was founded in 2015 and headquartered inHorsham, Pennsylvania.
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 436
- Lead/follow: no public data
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
- Leyden Labs — Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.
- Auron Therapeutics — A differentiated approach to cure cancer.
The Yield Lab invests in AgriFood Tech companies with technologies focused on crops, animal health, digital agriculture, logistics, and food ingredients. Initial investments range from $100,000 – $1.5M.
Show more...Investment focus
- Industry: Agriculture, Biotechnology, AgTech
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Argentina, Brazil
Investor stats
- Total investments: 60
- Lead/follow: no public data
Portfolio highlights
- Proba — Unlock the value of your climate actions with Proba. Transform your efforts into tradable carbon certificates, connect with partners, and create new revenue streams for your business. Schedule a call now.
- Sundew — Targeting water-borne pests and diseases
- Kaffe Bueno — Kaffe Bueno upcycles coffee waste into active and functional ingredients for cosmetics, nutraceuticals and functional foods.
Claret Capital provides specialty debt financing to European growth businesses, predominantly in the technology, life sciences and environmental sectors. Typical loan sizes range from €1M-€40M with the flexibility to do larger transactions opportunistically.They look for investment opportunities in high growth business with proven managementteams in need of capital to fuel organic growth, acquisitions, equipment purchases, bridge loans and various forms of recapitalization.
Show more...Investment focus
- Industry: Software, Information Technology, Mobile
- Stage:Debt Financing, Series A
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 91
- Lead/follow: no public data
Portfolio highlights
- Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
- Bitwala — The world's first 2-in-1 Bitcoin hardware wallet with integrated credit card and fingerprint authentication. Secure your digital assets with confidence.
- Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 894
- Lead/follow: no public data
Portfolio highlights
- Intent Inc — GroupUltra is a platform that allows users to program their groups and design their communities.
- Phoebe — Phoebe is an agentic search tool for tech stack data. It helps engineering teams to troubleshoot many sorts of problems much faster, from minor bugs to major incidents. Phoebe can also initiate searches proactively to help anticipate and triage new issues.
- Blue Water Autonomy — Blue Water Autonomy develops fully autonomous, unmanned ships designed from the keel up for long-endurance missions. Its vessels, about 100 feet and 100 tons, are purpose-built for open-ocean operations with modular payloads for logistics, surveillance, or munitions. The ships integrate hardware, software, and AI systems to operate independentlyover long durations. They are engineered for mass producibility, using medium-sized shipyards to keep production simpler and more cost-effective than traditional crewed ships. While initially focused on defense applications, the company also targets future use in commercial sectors such as cargo shipping, offshore energy, and other demanding maritime operations.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!VisVires New Protein is a pioneering investor focused on solving the persistent challenges of our food and feed system.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Health Care
- Stage:Series A, Series B
- Geography: France, Israel, Germany
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
- Infinite Roots — Mushlabs is a biotech company using fermentation to create the next generation of sustainable foods from the roots of mushrooms.
- Abolis Biotechnologies — Abolis is a biotech innovator providing sustainable, tailor-made solutions for food, health, cosmetics, and chemicals industries. Embrace biotechnology for a better future.
WxNW operates as an investment firm.
Show more...Investment focus
- Industry: Sales, Consumer, Marketing
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- UrbanFox — Discover cutting-edge AI data processing solutions tailored to your needs. Elevate your business with innovative technology, personalized service, and a commitment to excellence.
Moffett Investment Holdings is an investment firm
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Woodford Investment Management is a privately owned investment firm manages equity mutual funds. At Woodford, they don’t want to be just another fund management company. They want to create something different and better for their investors and they feel strongly that existing and potential clients are entitled to understand what they are doingwith their money.As investors, they are active, engaged, long-term, disciplined, diligent and focused. That’s a lot of things to say about their selves but each word is important in helping you to understand how they manage money – they will explain in more detail as they move along.Their investment approach and process are focused on value discovery, not price discovery. They believe that financial markets are inherently inefficient and that, through disciplined and diligent analysis, they can identify investment opportunities where market prices do not reflect long-term fundamental value. By exploiting this pervasive market characteristic, they believe they can create real long-term value for their investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 63
- Lead/follow: no public data
Portfolio highlights
- Revolut — Join 40+ million customers globally using Revolut to send money to 160+ countries, hold up-to 36 currencies in app, spend in 150+ currencies, and manage their money.
- Atom Bank — Explore our savings accounts, mortgages and business loans in our digital banking app. Compare our savings rates and join the future of secure digital banking. FSCS protected.
- Evofem Biosciences — Lithera is developing products for aesthetic medicine to address both medical and lifestyle indications. Its lead product is an injectable treatment to achieve local, selective fat tissue reduction (pharmaceutical lipoplasty). Using FDA registered drugs proven safe and effective in other indications, its product targets and stimulates natural fatmetabolism and achieves non-ablative, non-surgical fat tissue reduction in specific locations.
Conor Sheahan is the Founder and CEO of CKS Finance. He previously worked at Ocado Information Technology Limited as a Non-Executive Director. Conor Sheahan attended the Institute of Chartered Accountants in Ireland.
Show more...Investment focus
- Industry: Medical, Biopharma, Health Care
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
Declan Magee
Show more...Investment focus
- Industry: B2B, CRM, SaaS
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
- SalesOptimize — Sales/Marketing professionals love our Market Intelligence & B2B Sales Lead Platform with 120M+ B2B companies and 400M+ contacts. Join Today!
Feeding the world one investment at a time
Show more...Investment focus
- Industry: Biotechnology, Agriculture, Farming
- Stage:Series A, Series B
- Geography: United States, Canada, India
Investor stats
- Total investments: 23
- Round size: Series A $3.8M–$17M; Series B $4M–$20M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Covercress — An innovative new crop designed to benefit your farm and the future of agriculture.
- Plastomics — Plastomics is a biotechnology startup that focuses in developing the next generation of crops by using chloroplast genetic engineering. Its technology platform is applicable to different crops and traits. Plastomics provides solutions for the many current industry challenges.The company was founded in 2016 and headquartered in St. Louis,Missouri.
- Nanoguard Technologies — Temukan pengalaman bermain slot online di situs WSLOT888 dengan pilihan slot gacor hari ini, game slot88 populer, akses cepat, dan peluang jackpot besar setiap saat.
Cultivian Sandbox is a venture capital firm focused on building next-generation disruptive agriculture and food technology companies capable of generating superior returns. As early investors and active board members, we employ a hands-on approach to building companies and are often directly involved in setting company strategy, recruiting keyexecutives, and raising additional capital. Much more than simply a financial resource, we are capable of delivering tremendous value though active collaboration with our strategic partners and network, which are unparalleled in the agriculture and food industries.As both experienced operating managers and venture investors we add value to portfolio companies both through our highly skilled team and extensive industry network. Our investment team combines the domain expertise and investment experience from Cultivian Ventures and Sandbox Industries. Our expertise in sourcing, evaluating, closing, managing and ultimately exiting successful equity investments positions us not only to build stronger businesses, but reshape industries.
Show more...Investment focus
- Industry: Agriculture, Biotechnology, Farming
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 45
- Round size: Series A $2M–$23M; Series B $12M–$80M; Series C $13M–$22M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — raised $135M in 2019
Portfolio highlights
- Full Harvest — Waste less, profit more. Source imperfect and surplus fruits and vegetables up to 10-30% off.
- Descartes Labs — Enabling a better understanding of the physical world through the scalable analysis of geospatial data.
- Culture Biosciences — Culture Biosciences develops automated bio-reactor that helps biotech companies optimize their manufacturing processes and brings products to market faster. The company also builds automated tools for fermentation. It has a digital bio-manufacturing platform to enable scientists to run, monitor, and analyze bio-reactors faster than traditionalapproaches by robotic sample handling and cloud data monitoring and analysis.Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.
Medtech Syndicate Nominee
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
- Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
We are dedicated to helping investors reach their investment goals. Get in touch with our team to explore Aberdeen's investment options.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Series A
- Geography: United States, Switzerland, France
Investor stats
- Total investments: 50
- Round size: Series A $10M–$65M; Series B $20M–$215M; Series C $28M–$133M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Oculis — Experience the Future of Eye Care: Oculis, a Clinical Biopharmaceutical Innovator, Pioneering Breakthrough Treatments for Ophthalmic Diseases & Transforming Lives Globally.
- Priothera — Priothera is a clinical-stage company developing orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies. We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic HematopoieticStem Cell Transplantation (HSCT) in these patients.
- Endeavor BioMedicines — Endeavor BioMedicines is a clinical-stage biotechnology company developing transformational medicines for life-threatening diseases.
Biotechnology Investor funding in Ireland at a glance
Stats across 198 deals from 206 investors.
Access all 206 investors in Ireland Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 206 investors investing in Ireland Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!